The Business Times
business-time-50

Singapore has a chance to shine in precision medicine

Existing research capabilities and support for new startups can drive growth in this field

google-preferred-sourceAdd BT as a preferred source
    • Singapore’s strengths position it to ride the precision-medicine wave. The country has deep research and development and clinical expertise, strengths in genomics, and a burgeoning biomedical industry.
    • Singapore’s strengths position it to ride the precision-medicine wave. The country has deep research and development and clinical expertise, strengths in genomics, and a burgeoning biomedical industry. PHOTO: BT FILE

    Clarice Chen

    Published Fri, Sep 20, 2024 · 05:00 AM

    IMAGINE if the medicine prescribed to you could be tailored to your genetic makeup. This would prevent instances of drugs having no effect – or worse, making you sicker.

    With precision medicine, this is not merely a matter of imagination. Nalagenetics, a spin-off of the Agency for Science, Technology and Research (A*Star), aims to do just this.

    The company is working with the National University Hospital and Raffles Medical Group on something called “pre-emptive pharmacogenomics”. This involves understanding a patient’s genomic profile and cross-checking it with biomarkers, to pre-emptively flag any issues with medication.

    Medical researchHealthcareMedicineEnterprise Singapore

    TRENDING NOW

    Grant Wee built Hideaway as a massage-and-bathhouse concept centred on solitude and recovery.

    UOB CEO’s youngest child Grant Wee turns burnout into a wellness business

    HSBC Singapore CEO Wong Kee Joo says the expansion “reflects our confidence in the country’s future as a leading wealth, trade, and innovation hub”.

    Wanted: 100 AI specialists, 100 wealth relationship managers at HSBC Singapore

    This marks the second-largest initial public offering in China’s history.

    China chipmaker CXMT jumps 472% in debut after US$9.8 billion IPO

    A combined CapitaLand-Mapletree group would be better positioned to compete, and it would raise the profile of the Singapore market.

    Temasek should publicly state its position on the long-rumoured CapitaLand-Mapletree merger

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More